结直肠癌BRAF突变的影像学预测因素
本研究纳入2004年9月至2018年10月单中心155例经BRAF检测的结直肠癌患者,评估影像表现与BRAF状态的关系。BRAF突变更多见于女性、年龄较大、右半结肠、息肉样或肿块样形态及不均匀强化者,且非腹膜转移和总体转移发生率较低。逻辑回归显示右半结肠位置、肿瘤不均匀强化及无非腹膜转移是预测BRAF突变的独立因素。
要点
- 右半结肠、息肉样或肿块样形态及不均匀强化提示BRAF突变可能。
- BRAF突变者非腹膜转移及总体转移发生率低于野生型。
- 女性、年龄较大与BRAF突变显著相关。
关键影像表现/征象
- BRAF突变肿瘤多见于右半结肠(p=0.001)。
- BRAF突变肿瘤更多表现为息肉样或肿块样形态(p=0.019)。
- BRAF突变肿瘤更多表现为不均匀强化(p=0.009)。
- BRAF突变者非腹膜转移发生率低于野生型(p=0.013)。
- BRAF突变者总体转移发生率低于野生型(p=0.004)。
诊断标准与关键数值
- 逻辑回归显示右半结肠位置(p=0.002)为BRAF突变的显著预测因素。
- 逻辑回归显示肿瘤不均匀强化(p=0.039)为BRAF突变的显著预测因素。
- 逻辑回归显示无非腹膜转移(p=0.043)为BRAF突变的显著预测因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Colorectal cancer (CRC) is one of the leading causes of cancer deaths and is associated with various genetic mutations. BRAF mutations, found in approximately 10% of all CRCs, are associated with negative predictive outcomes. The goal of this study was to assess the relationship between the imaging findings and BRAF statuses of CRC patients.
MATERIALS AND METHODS: The study population was colorectal cancer patients who underwent biopsy or surgery in a single institution from September 2004 to October 2018, and in whom the pathologic specimens were tested for BRAF mutation. The exclusion criteria were (1) patients without pre-operative cross-sectional imaging, and (2) patients whose tumors were invisible on imaging. Two hundred and eighty-three patients met the inclusion criteria. Among them, 128 were excluded, and a total of 155 patients were enrolled in the study.
RESULTS: BRAF mutations were significantly more common in female patients (p = 0.007). Patients with mutated BRAF were significantly older than those with wild-type BRAF (p = 0.001). BRAF-mutant tumors were predominant in right-sided colon (p = 0.001) with higher numbers of polypoid- or mass-like morphology (p = 0.019) and heterogeneous enhancement (p = 0.009). Compared to their wild-type counterparts, BRAF-mutated CRCs have a lower occurrence of non-peritoneal, and overall metastases (p = 0.013 and p = 0.004, respectively). Logistic regression analysis showed three significant factors for the prediction of BRAF mutations in CRC patients: right-sided location (p = 0.002), heterogeneous tumor enhancement (p = 0.039), and lack of non-peritoneal metastasis (p = 0.043).
CONCLUSION: By recognizing the specific imaging features of BRAF-mutant CRCs, it would be possible to identify a patient who has a higher risk of carrying BRAF mutation.
引用
- Eurboonyanun K, Lahoud RM, Kordbacheh H, et al. Imaging predictors of BRAF mutation in colorectal cancer. Abdom Radiol (NY). 2020. PMID: 32193591. doi:10.1007/s00261-020-02484-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。